ULK1 and diabetes mellitus: In previous studies, MSCs have been shown to alleviate the muscle atrophy caused by diabetes and obesity through sEV-mediated enhancement of AMPK/ULK1-driven autophagy [25], thereby extending the therapeutic duration of stem cells [26].